NASDAQ:NVCN
Delisted
Neovasc Inc. Stock News
$30.03
+0 (+0%)
At Close: Jul 07, 2023
Neovasc to Participate in 10th Annual SVB Leerink Global Healthcare Conference
09:00am, Wednesday, 17'th Feb 2021
Vancouver, British Columbia--(Newsfile Corp. - February 17, 2021) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN), today announced that company management will be participating in the 10th Annual SVB Leer
Neovasc Announces Closing of US$72 Million Registered Direct Offering of Common Shares Priced At-The-Market
03:53pm, Friday, 12'th Feb 2021
Vancouver, British Columbia--(Newsfile Corp. - February 12, 2021) - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN) (TSX: NVCN) announced today that it has closed its previously announced sal
Neovasc Announces Closing of US$72 Million Registered Direct Offering of Common Shares Priced At-The-Market
03:34pm, Friday, 12'th Feb 2021
VANCOUVER, CANADA, Feb. 12, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. (“Neovasc” or the “Company”) (Nasdaq: NVCN / TSX: NVCN) announced today that it has closed its previou
Neovasc Announces US$72 Million Registered Direct Offering Priced At-The-Market
07:38am, Wednesday, 10'th Feb 2021
Vancouver, British Columbia--(Newsfile Corp. - February 10, 2021) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") announced today that it has entered into definitive agreements
Neovasc Announces US$72 Million Registered Direct Offering Priced At-The-Market
07:31am, Wednesday, 10'th Feb 2021
Vancouver, Canada, Feb. 10, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. (“Neovasc” or the “Company”) (Nasdaq: NVCN / TSX: NVCN) announced today that it has entered into definit
NVCN Stock Price Increases Over 30% Pre-Market: Why It Happened
07:07am, Wednesday, 10'th Feb 2021
The stock price of Neovasc Inc (NASDAQ: NVCN) is trading at over 30% pre-market as of 7 AM ET. This is why it happened.
Neovasc Regains Compliance with Nasdaq Minimum Bid Price Rule
09:00am, Tuesday, 09'th Feb 2021
Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - February 9, 2021) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") announced today that it has received
Neovasc Comments on Journal of the American Heart Association Publication
09:00am, Friday, 05'th Feb 2021
Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - February 5, 2021) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") today announced that the Journal of
Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - February 2, 2021) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") today announced that the German Inst
VANCOUVER and MINNEAPOLIS, MN, Feb. 02, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) today announced that the German Institute for t
American Medical Association Issues New CPT Code for Neovasc Reducer Procedure
08:00am, Friday, 29'th Jan 2021
VANCOUVER and MINNEAPOLIS, Jan. 29, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) announced today that the American Medical Association
Neovasc Reducer Featured in Three Peer Reviewed Publications Supporting Reducer Therapy
08:33am, Tuesday, 19'th Jan 2021
Vancouver, Bristish Columbia and Minneapolis, Minnesota--(Newsfile Corp. - January 19, 2021) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") announced today that the Neovasc Red
Neovasc Reducer Featured in Three Peer Reviewed Publications Supporting Reducer Therapy
08:30am, Tuesday, 19'th Jan 2021
VANCOUVER and MINNEAPOLIS, MN, Jan. 19, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. (“Neovasc” or the “Company”) (Nasdaq, TSX: NVCN) announced today the Neovasc Reducer™ (
Neovasc Responds to FDA Not-Approvable Letter Regarding Neovasc Reducer(TM)
05:14pm, Friday, 15'th Jan 2021
Vancouver, British Columbia--(Newsfile Corp. - January 15, 2021) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") announced today that it has received a "not-approvable" lett
Neovasc Responds to FDA Not-Approvable Letter Regarding Neovasc Reducer™
04:59pm, Friday, 15'th Jan 2021
VANCOUVER and MINNEAPOLIS, Jan. 15, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. (“Neovasc” or the “Company”) (Nasdaq, TSX: NVCN) announced today that it has received a “not-app
